VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $58,581,000 | -1.0% | 2,300,000 | 0.0% | 0.84% | -15.0% |
| Q1 2022 | $59,156,000 | -25.1% | 2,300,000 | 0.0% | 0.98% | -31.5% |
| Q4 2021 | $78,959,000 | -49.2% | 2,300,000 | -35.6% | 1.44% | -53.4% |
| Q3 2021 | $155,473,000 | -13.5% | 3,572,438 | -6.0% | 3.08% | -6.2% |
| Q2 2021 | $179,664,000 | -7.8% | 3,800,000 | 0.0% | 3.28% | -6.9% |
| Q1 2021 | $194,826,000 | +51.6% | 3,800,000 | -20.8% | 3.52% | +51.6% |
| Q4 2020 | $128,544,000 | -22.0% | 4,800,000 | 0.0% | 2.32% | -12.0% |
| Q3 2020 | $164,784,000 | -16.2% | 4,800,000 | 0.0% | 2.64% | -13.4% |
| Q2 2020 | $196,656,000 | +282.6% | 4,800,000 | +220.0% | 3.05% | +240.2% |
| Q1 2020 | $51,405,000 | – | 1,500,000 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |